Patents by Inventor Heather Hain

Heather Hain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS
    Publication number: 20230304018
    Abstract: Compositions and methods for the detection and treatment of obesity and other neurological disorders are provided.
    Type: Application
    Filed: October 17, 2022
    Publication date: September 28, 2023
    Applicant: The Children's Hospital of Philadelphia
    Inventors: Hakon Hakonarson, Rahul Pandey, Marina Bakay, Heather Hain
  • COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH CLEC16A DYSFUNCTION OR LOSS
    Publication number: 20220339156
    Abstract: Compositions and methods for the treatment of CLEC16A associated disorders are disclosed.
    Type: Application
    Filed: September 9, 2020
    Publication date: October 27, 2022
    Applicant: THE CHILDREN'S HOSPITAL OF PHILADELPHIA
    Inventors: Hakon Hakonarson, Rahul Pandey, Marina Bakay, Heather Hain
  • COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS
    Publication number: 20200385739
    Abstract: Compositions and methods for the detection and treatment of obesity and other neurological disorders are provided.
    Type: Application
    Filed: September 7, 2018
    Publication date: December 10, 2020
    Inventors: Hakon Hakonarson, Rahul Pandey, Marina Bakay, Heather Hain
  • Methods For Treating Inflammatory Conditions
    Publication number: 20170173004
    Abstract: The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising tenilsetam or pharmaceutically acceptable salts thereof that are useful in modulating inflammation. In particular, the compounds or pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder involving inflammation, including, but not limited to, delayed type hypersensitivity and contact hypersensitivity.
    Type: Application
    Filed: August 8, 2016
    Publication date: June 22, 2017
    Inventors: Andrew Reaume, Heather Hain, Michael S. Saporito
  • Methods for treating inflammatory conditions
    Patent number: 9408844
    Abstract: The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising tenilsetam or pharmaceutically acceptable salts thereof that are useful in modulating inflammation. In particular, the compounds or pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder involving inflammation, including, but not limited to, delayed type hypersensitivity and contact hypersensitivity.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: August 9, 2016
    Assignee: Melior Discovery, Inc.
    Inventors: Andrew Reaume, Heather Hain, Michael S. Saporito
  • Methods For Treating Inflammatory Conditions
    Publication number: 20140227209
    Abstract: The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising tenilsetam or pharmaceutically acceptable salts thereof that are useful in modulating inflammation. In particular, the compounds or pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder involving inflammation, including, but not limited to, delayed type hypersensitivity and contact hypersensitivity.
    Type: Application
    Filed: April 17, 2014
    Publication date: August 14, 2014
    Applicant: Melior Discovery, Inc.
    Inventors: Andrew Reaume, Heather Hain, Michael S. Saporito
  • Methods for treating inflammatory conditions
    Patent number: 8716294
    Abstract: The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising tenilsetam or pharmaceutically acceptable salts thereof that are useful in modulating inflammation. In particular, the compounds or pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder involving inflammation, including, but not limited to, delayed type hypersensitivity and contact hypersensitivity.
    Type: Grant
    Filed: November 9, 2007
    Date of Patent: May 6, 2014
    Assignee: Melior Discovery, Inc.
    Inventors: Andrew Reaume, Heather Hain, Michael Saporito
  • Methods For Treating Inflammatory Conditions
    Publication number: 20080161319
    Abstract: The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising tenilsetam or pharmaceutically acceptable salts thereof that are useful in modulating inflammation. In particular, the compounds or pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder involving inflammation, including, but not limited to, delayed type hypersensitivity and contact hypersensitivity.
    Type: Application
    Filed: November 9, 2007
    Publication date: July 3, 2008
    Applicant: MELIOR DISCOVERY, INC.
    Inventors: Andrew Reaume, Heather Hain, Michael Saporito